Multicenter. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases48

Recurrence Disease Progression Postoperative Complications Acute Disease Neutropenia Stroke Breast Neoplasms Myocardial Infarction Neoplasm Recurrence, Local Hemorrhage Nausea HIV Infections Coronary Artery Disease Neoplasm Metastasis Lung Neoplasms Coronary Restenosis Critical Illness Graft Occlusion, Vascular Heart Failure Chronic Disease Vomiting Lymphoma, Non-Hodgkin Osteoarthritis, Knee Drug-Related Side Effects and Adverse Reactions Pain Neoplasms Adenocarcinoma Fever Hematologic Diseases Tachycardia, Ventricular Colorectal Neoplasms Prosthesis Failure Anemia Bacteremia Thrombocytopenia Kidney Failure, Chronic Coronary Stenosis Brain Ischemia Adnexal Diseases Coronary Disease Death, Sudden, Cardiac Acquired Immunodeficiency Syndrome Bronchiolitis Cross Infection Sepsis Multiple Myeloma Aortic Aneurysm, Abdominal Fatigue

Chemicals and Drugs58

Placebos Antineoplastic Agents Paclitaxel Deoxycytidine Immunosuppressive Agents Fluorouracil Anti-Bacterial Agents Antibodies, Monoclonal, Humanized Antibodies, Monoclonal Cisplatin Cardiovascular Agents Cyclophosphamide Doxorubicin Reagent Kits, Diagnostic Prednisone Taxoids Biological Markers Anticoagulants Organoplatinum Compounds Sirolimus Vincristine Methotrexate Platelet Aggregation Inhibitors Triazoles Fluocinolone Acetonide Dacarbazine Leucovorin Antirheumatic Agents Drug Combinations Coated Materials, Biocompatible Antifungal Agents Vinblastine Antibodies, Monoclonal, Murine-Derived Polytetrafluoroethylene Thalidomide Delayed-Action Preparations Aspirin Carboplatin Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic Fibrinolytic Agents Tryptamines Adrenal Cortex Hormones Tacrolimus Recombinant Proteins Camptothecin Anti-Infective Agents Etoposide Epirubicin Interferon-alpha Glucocorticoids Mitoxantrone Dexamethasone Hypoglycemic Agents Hematinics Cilastatin Granulocyte Colony-Stimulating Factor Mycophenolic Acid

Analytical, Diagnostic and Therapeutic Techniques and Equipment109

Multicenter Studies as Topic Treatment Outcome Prospective Studies Double-Blind Method Follow-Up Studies Drug Administration Schedule Survival Analysis Risk Factors Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Disease-Free Survival Severity of Illness Index Survival Rate Drug Therapy, Combination Cohort Studies Kaplan-Meier Estimate Placebos Single-Blind Method Sensitivity and Specificity Reproducibility of Results Prognosis Predictive Value of Tests Research Design Infusions, Intravenous Risk Assessment Clinical Protocols Administration, Oral Multivariate Analysis Registries Incidence Proportional Hazards Models Combined Modality Therapy Logistic Models Neoplasm Staging Patient Selection Feasibility Studies Remission Induction Randomized Controlled Trials as Topic Treatment Failure Clinical Trials as Topic Chi-Square Distribution Stents Endpoint Determination Prosthesis Design Questionnaires Defibrillators, Implantable Coronary Angiography Case-Control Studies Pilot Projects Longitudinal Studies Reagent Kits, Diagnostic Pain Measurement Angioplasty, Balloon, Coronary Evaluation Studies as Topic Injections, Subcutaneous Tomography, X-Ray Computed Odds Ratio Observer Variation Equipment Design Retreatment Prevalence Salvage Therapy Injections, Intravenous ROC Curve Chemotherapy, Adjuvant Blood Vessel Prosthesis Implantation Drug-Eluting Stents Length of Stay Blood Vessel Prosthesis Hospital Mortality Statistics, Nonparametric Cross-Sectional Studies Analysis of Variance Reoperation Regression Analysis Confidence Intervals Risk Blood Transfusion Moxibustion Cross-Over Studies Probability Microbial Sensitivity Tests Respiration, Artificial Sample Size Delayed-Action Preparations Transplantation, Autologous Reference Values Magnetic Resonance Imaging Hospitalization Abdominal Wound Closure Techniques Biopsy Linear Models Prosthesis Failure Equipment Safety CD4 Lymphocyte Count Neoadjuvant Therapy Electrocardiography Maximum Tolerated Dose Reference Standards Karnofsky Performance Status Thrombolytic Therapy Kidney Transplantation False Negative Reactions Area Under Curve Ultrasonography, Interventional Renal Dialysis Hematopoietic Stem Cell Transplantation Clinical Trials, Phase III as Topic Stroke Volume

Psychiatry and Psychology2

Pain Patient Compliance

Phenomena and Processes17

Time Factors Sensitivity and Specificity Dose-Response Relationship, Drug Chi-Square Distribution Odds Ratio Recovery of Function Pregnancy Risk Probability Pain Vascular Patency CD4 Lymphocyte Count Maximum Tolerated Dose Genotype Area Under Curve Graft Rejection Stroke Volume

Disciplines and Occupations2

Research Design Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life International Cooperation

Technology, Industry, Agriculture4

Quality Control Coated Materials, Biocompatible Polytetrafluoroethylene Automation

Humanities2

Quality of Life Ethics Committees, Research

Information Science6

Survival Rate Registries Incidence Questionnaires Prevalence Hospital Mortality

Named Groups1

Infant, Newborn

Health Care66

Multicenter Studies as Topic Treatment Outcome Prospective Studies Double-Blind Method Follow-Up Studies Survival Analysis Risk Factors Retrospective Studies Disease-Free Survival Severity of Illness Index Survival Rate Cohort Studies Kaplan-Meier Estimate Single-Blind Method Sensitivity and Specificity Reproducibility of Results Predictive Value of Tests Risk Assessment Clinical Protocols Multivariate Analysis Registries Incidence Proportional Hazards Models Logistic Models Patient Selection Feasibility Studies Randomized Controlled Trials as Topic Treatment Failure Clinical Trials as Topic Chi-Square Distribution Safety Intention to Treat Analysis Age Factors Laboratories Questionnaires Case-Control Studies Pilot Projects Longitudinal Studies Intensive Care Units Evaluation Studies as Topic Odds Ratio Observer Variation Prevalence ROC Curve Length of Stay Hospital Mortality Outcome Assessment (Health Care)Statistics, Nonparametric Cross-Sectional Studies Analysis of Variance Regression Analysis Confidence Intervals Risk Cross-Over Studies Probability Sample Size Sex Factors Hospitalization Ethics Committees, Research Comorbidity Linear Models Karnofsky Performance Status Patient Compliance Clinical Trials Data Monitoring Committees Area Under Curve Clinical Trials, Phase III as Topic

Publication Characteristics1

Multicenter Study

Geographicals16

Italy Europe United States Germany France Japan Spain Republic of Korea Canada Austria Netherlands Belgium North America Switzerland China Argentina

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Publication Characteristics Geographicals

Multicenter Studies as Topic Treatment Outcome Prospective Studies Double-Blind Method Follow-Up Studies Time Factors Drug Administration Schedule Survival Analysis Risk Factors Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Disease-Free Survival Severity of Illness Index Survival Rate Italy Europe Drug Therapy, Combination Cohort Studies Kaplan-Meier Estimate Placebos Single-Blind Method Sensitivity and Specificity Reproducibility of Results Recurrence Prognosis Predictive Value of Tests Research Design Infusions, Intravenous Risk Assessment United States Germany Quality of Life France Clinical Protocols Administration, Oral Multivariate Analysis Registries Disease Progression Incidence Dose-Response Relationship, Drug Proportional Hazards Models Combined Modality Therapy Postoperative Complications Japan Logistic Models Neoplasm Staging Patient Selection Feasibility Studies Spain Remission Induction Randomized Controlled Trials as Topic Infant, Newborn Treatment Failure Antineoplastic Agents Clinical Trials as Topic Acute Disease Chi-Square Distribution Paclitaxel Republic of Korea Quality Control Multicenter Study Stents Endpoint Determination Prosthesis Design Safety Intention to Treat Analysis Deoxycytidine Age Factors Immunosuppressive Agents Fluorouracil Anti-Bacterial Agents Neutropenia Laboratories Antibodies, Monoclonal, Humanized Stroke Questionnaires Breast Neoplasms Defibrillators, Implantable Antibodies, Monoclonal Myocardial Infarction Coronary Angiography Cisplatin Case-Control Studies Cardiovascular Agents Cyclophosphamide Pilot Projects Neoplasm Recurrence, Local Doxorubicin Longitudinal Studies Reagent Kits, Diagnostic Pain Measurement Angioplasty, Balloon, Coronary Hemorrhage Intensive Care Units Prednisone Evaluation Studies as Topic Injections, Subcutaneous Tomography, X-Ray Computed Odds Ratio Observer Variation

No FAQ available that match "multicenter"